Valve-in-Valve in the Tricuspid Position for a Stenosed Bioprosthesis
DOI:
https://doi.org/10.1532/HSF98.20121106Abstract
The strategy of transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves is a documented approach. It allows one to avoid performing a high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has been documented only a few times in the literature. We report the case of a 65-year-old woman with a failing bioprosthetic tricuspid valve who had undergone 3 prior open heart operations. We attempted a transatrial transcatheter approach and successfully deployed a 29-mm Edwards Sapien balloon-expandable bioprosthesis into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach.References
Kenny D, Hijazi ZM, Walsh KP. 2011. Transcatheter tricuspid valve replacement with the Edwards SAPIEN valve. Catheter Cardiovasc Interv 78:267-70.nLauten A, Figulla HR, Willich C, et al. 2010. Heterotopic valve replacement as an interventional approach to tricuspid regurgitation. J Am Coll Cardiol 55:499-500.nRoberts P, Spina R, Vallely M, Wilson M, Bailey B, Celermajer DS. 2010. Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circ Cardiovasc Interv 3:e14-5.nWebb JG, Wood DA, Ye J, et al. 2010. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 121:1848-57.nZajarias A, Cribier AG. 2009. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 53:1829-36.n
